Who We Are · Press · Login · Contact

New VDI-TK canine+ blood test helps to detect cancer in dogs


Canine Cancer affects one out of every three dogs. Of those, over half of them will die of cancer.

So it’s great news that a new blood test helps to detect cancer in dogs – possibly allowing early treatment and increasing survival rates.

The National Canine Cancer Foundation, a 501 (c)(3) non-profit corporation dedicated to eliminating Cancer as a major health issue in dogs, has revealed VDI-TK canine+, an innovative, patent-pending, dual-biomarker panel for the diagnostic, prognostic, and therapeutic monitoring of dogs with cancer.

Veterinary Diagnostic Lab says “has been a long standing and studied relationship between cancer and inflammation. Research shows that inflammation plays an essential role at each stage of the disease (initiation and proliferation), and has demonstrated that the effectiveness of tumor development correlates directly with the degree of the inflammatory reactions.” The test can be used in the diagnostic process, even before tumors appear, and during treatment to measure the degree of inflammation. When inflammation goes down, treatment may be working.

However, the National Canine Cancer Foundation warns on its Facebook page that TKCanine+ is a good adjunct to other tests, not a substitute for them, and is not, in itself, diagnostic.

The principle element, or biomarker, that VDI -TKcanine+ measures in the dog’s blood is an enzyme called thymidine kinase or TK for short. TK is released into the blood stream by cells that are undergoing unusually rapid cell division; a hallmark of cancer.

Having lost my wonderful Yellow Lab, Sammy, (above) to Lymphoma when he was 13, and watched so many of my friends’ dogs succumb to cancer, it’s great to hear any progress being made in canine cancer.

Researchers: Dog Slobber May Lead to a Canine – and Human – Cancer Cure

Add a Comment